Patent application number | Description | Published |
20100172534 | MAGNETIC STRUCTURE FOR AN IRONLESS ELECTRODYNAMIC-LOUDSPEAKER MOTOR, MOTORS AND LOUDSPEAKERS - A magnetic structure generating a magnetic field for an ironless motor of an electrodynamic loudspeaker having a mobile coil, wherein the magnetic structure generates a magnetic field in a gap in which the coil is arranged. The magnetic structure includes of a stack of three magnets corresponding to one intermediate magnet and two top and bottom covering magnets, the magnets forming a straight gap border and being located side by side, the intermediate magnet having a radial magnetic polarization, the covering magnets having identical magnetic polarizations and remanent magnetizations. The covering magnets have a radial or axial magnetic polarization. When magnetic polarization of the covering magnets is radial, remanent magnetization of each covering magnet is higher than remanent magnetization of the intermediate magnet, and when magnetic polarization of the covering magnets is axial, remanent magnetization of each covering magnet is lower than remanent magnetization of the intermediate magnet. Motors are provided. | 07-08-2010 |
20110286623 | MOVING PART AND ELECTRODYNAMIC TRANSDUCER PROVIDED WITH SUCH A MOVING PART - The invention relates to a moving part for an electro-dynamic transducer, including at least one mandrel supporting a winding of at least one coiled wire. The mandrel includes at least one first element rigidly connected inside at least one second element for guiding the moving part inside the transducer. The first element has a winding support for the coiled wire so that the coil is located inside the mandrel, as well as vibration transmitter, such as a diaphragm, the vibration being generated by the movement of the coil induced by the flow of current in the coil wire. The invention also relates to an electro-dynamic transducer including such a moving part. | 11-24-2011 |
Patent application number | Description | Published |
20090264429 | Aryl - Hydroxyethylamino - Pyrimidines and Triazines as Modulators of Fatty Acid amide Hydrolase - Certain aryl-hydroxyethylamino-pyrimidine and triazine compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed. | 10-22-2009 |
20110230490 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 09-22-2011 |
20120088741 | ARYL-SUBSTITUTED HETEROCYCLIC UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain aryl-substituted heterocyclic urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). | 04-12-2012 |
20140066412 | HETEROARYL SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 03-06-2014 |
20140135311 | TETRAHYDRO-PYRIMIDOAZEPINES AS MODULATORS OF TRPV1 - Certain tetrahydro-pyrimidoazepine compounds are described, which are useful as TRPV1 modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by TRPV1. Thus, the compounds may be administered to treat, e.g., pain, itch, cough, asthma, or inflammatory bowel disease. | 05-15-2014 |
20140221322 | HETEROARYL SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 08-07-2014 |
Patent application number | Description | Published |
20090062294 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 03-05-2009 |
20130245022 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE - Certain heteroaryl-substituted piperidinyl and piperazinyl urea compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, insulin resistance, diabetes, osteoporosis, and movement disorders (e.g., multiple sclerosis). | 09-19-2013 |